Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus reuteri DSM 17938 and Improved Stool Type

Doses used in studies

CFU/day: 100 million (median 100 million, IQR 100 million–100 million) — 1 study

Time to effect

Median: 4 months · IQR 4 months–4 months · Range 4 months–4 months — Reported in 1 of 1 study

1 of 1 paper

Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study.
- 2017-06
- RCT · n = 55
- Journal of pediatric gastroenterology and nutrition 64(6)
- - Oleg Jadrešin
  - Iva Hojsak
  - Zrinjka Mišak
  - Alemka Jaklin Kekez
  - Tena Trbojević
  - Lana Ivković
  - Sanja Kolaček
- PubMed: 27906800
- DOI: 10.1097/mpg.0000000000001478
4 Insights on
- Improved Stool Type
- High evidence
- Clinical
The 2 groups did not differ in the duration of abdominal pain, stool type, or absence from school.
Effect
Neutral
Effect size
Small
Significant
No
Dose
10^8 CFU daily